Home » Blog » Improving clinical trial enrollment to help accelerate the time to market for new therapeutics

Published on

Improving clinical trial enrollment to help accelerate the time to market for new therapeutics

By leveraging Quest’s relationship with half the country’s physicians and hospitals, a leading pharmaceutical company was able to identify over 1,000 additional physicians to approach for clinical trial participation or physician referral to study sites. This could allow for a higher rate of patient enrollment and improved cost-effectiveness—streamlining clinical trial operations to help bring new medicines to market in a timely fashion.

Read the case study about how we helped one organization expand access to physicians and locations.

Subscribe me to the blog